Ji Ming Wang

Title: The Innovations of Ji Ming Wang

Introduction

Ji Ming Wang is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of immunology. With a total of 2 patents, his work has implications for therapeutic and prophylactic applications.

Latest Patents

Wang's latest patents include T20/DP178, which is an activator of human phagocyte formyl peptide receptors. This invention relates to the discovery that T20/DP178, T21/DP107, and fragments thereof interact with members of the formyl peptide receptor family, thereby modulating cell migration and activation. The patent discloses novel biological tools, prophylactics, therapeutics, and methods for modulating an inflammatory response. Another significant patent involves chemotactic agents for T-cells, which discusses the chemotactic activity of defensins and CAP37. This patent also provides methods of treatment associated with such activity and compositions for such treatment.

Career Highlights

Throughout his career, Ji Ming Wang has worked with esteemed organizations, including the United States of America as represented by the Public Health Service and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has been pivotal in advancing our understanding of immune responses and potential treatments.

Collaborations

Wang has collaborated with notable colleagues such as Joost J Oppenhelm and Dennis Michiel, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Ji Ming Wang's contributions to biomedical research and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence therapeutic strategies and our understanding of immune mechanisms.